Schedule 13G ownership disclosure

CRISPR Therapeutics AG

Common Stock · CUSIP: H17182108

Event date: 2024-12-31

Filing-level shares
8,973,063.00
Percent of class
10.51%
  • ARK Investment Management LLC

    Shares: 8,973,063.00 · Class: 10.51%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-013688
Form type
SCHEDULE 13G/A
Filer
ARK Investment Management LLC
CIK
CIK 1697748
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub